HPC
SANA icon

HM Payson & Co’s Sana Biotechnology SANA Stock Holding History

HM Payson & Co’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-391
Closed -$13K – 1157
2021
Q1 		$13K Buy
+391
New +$12.7K ﹤0.01% 841

Other funds holding SANA

FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Public Sector Pension Investment Board (PSP Investments)
Public Sector Pension Investment Board (PSP Investments) Montreal, Quebec, Canada $38.7B AUM 44.46% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $53.5M AUM 80.67% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
SM
SB Management Abu Dhabi, United Arab Emirates $516M AUM 40.71% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

HM Payson & Co's SANA Position: Q2 2021 in Review

HM Payson & Co sold out of Sana Biotechnology (SANA) in Q2 2021, closing a stake of 391 shares — an estimated $13K sold.

HM Payson & Co first reported a position in SANA in Q1 2021 and held it in 1 quarter. The position peaked at $13K in Q1 2021. 80 funds tracked by Wall St. Rank hold SANA as of Q2 2021.

  • HM Payson & Co reported no remaining Sana Biotechnology position as of Q2 2021 after selling out during the quarter.
  • HM Payson & Co sold 391 Sana Biotechnology shares in Q2 2021, an estimated $13K.
  • HM Payson & Co first reported a position in Sana Biotechnology in Q1 2021 and held it in 1 quarter.
  • HM Payson & Co's Sana Biotechnology position peaked at $13K in Q1 2021.
  • 80 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2021.

Based on HM Payson & Co's 13F filing for Q2 2021, filed 17 Aug 2021.